Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

Producer of functional foods and supplements for manufacturing and distribution.

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK

Description

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-08 15:20
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
MCD - dokument ofertowy (seria E)
Polish 444.1 KB
2023-12-29 22:27
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 728 bytes
2023-11-29 14:02
MCD - Dokument ofertowy
Polish 400.2 KB
2023-11-29 14:02
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.5 KB
2023-10-23 21:09
Formularz zapisu - seria E
Polish 168.3 KB
2023-10-23 21:09
Dokument Ofertowy - seria E
Polish 353.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cogent Biosciences, Inc. Logo
A clinical-stage biotech company developing precision therapies for genetic diseases.
United States of America
COGT
Coherus Oncology, Inc. Logo
Biopharmaceutical company developing and commercializing immuno-oncology therapies.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
A biopharmaceutical company developing abuse-deterrent pain management medications.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops plant-derived collagen for 3D bioprinting of tissues and organs.
United States of America
CLGN
COMPASS Pathways plc Logo
Develops psilocybin treatments for difficult-to-treat mental health conditions.
United States of America
CMPS
Compass Therapeutics, Inc. Logo
Clinical-stage biopharma developing antibody-based therapeutics for oncology.
United States of America
CMPX
Connect Biopharma Holdings Ltd Logo
A clinical-stage biopharma developing therapies for T cell-driven inflammatory diseases.
United States of America
CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America
CNTX
Contineum Therapeutics, Inc. Logo
Clinical-stage biopharma developing oral small molecule therapies for NI&I conditions.
United States of America
CTNM
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage biopharma developing targeted therapies for oncology and obesity.
United States of America
CRBP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.